An Evaluation of AZR-MD-001 as Treatment for Meibomian Gland Dysfunction (MGD) or Contact Lens Discomfort (CLD)

Phase 2 Completed 26 enrolled Azura Ophthalmics The University of New South Wales · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

SOVS2019-070 is a single-center study of AZR-MD-001 ointment and AZR-MD-001 vehicle in patients with Meibomian Gland Dysfunction (MGD) or Contact Lens Discomfort (CLD).

Timeline

Start: 2019-10-04
Primary completion: 2020-12-11
Completion: 2020-12-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	AZR-MD-001	Unknown	—	—

An Evaluation of AZR-MD-001 as Treatment for Meibomian Gland Dysfunction (MGD) or Contact Lens Discomfort (CLD)

Summary

Timeline

Drugs

Indications